Portland, OR -- (SBWire) -- 05/13/2019 --The North American biosurgery market offers lucrative growth opportunities owing to its developed economy, high public awareness, rising patient pool, and arrival of new multifunctional products. Developing countries such as India, China, Brazil, and South Korea are expected to boost the market growth with rapid change in healthcare infrastructure and increase in purchasing power. Increase in medical tourism, heavy investment by top players in R&D activities, and low cost surgeries are projected to boost the market growth during the analysis period, particularly in the Asia-Pacific region.
Biosurgery Market report, published by Allied Market Research, forecasts that the global market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/1235
Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for preventing excessive blood loss or providing adhesion or wound/tissue sealing, and repair of damaged or weakened tissues or bones of a body. These advanced products enhance the work efficiency of physicians by controlling surgery-related difficulties in expensive and complicated surgeries.
The biosurgery market is projected to grow at a substantial rate owing to rise in sport & spine-related injuries, per capita healthcare expenditure, rise in the number of surgeries due to increase in obese population along with lifestyle disorders and others. Also, availability of multi-functional products would provide a lucrative market opportunity; for instance, apart from fibrins use as surgical sealants, it is also used as hemostatic agents to prevent excessive blood loss during cardiothoracic and orthopedic surgeries. However, factors that would hamper the market growth are high cost associated with surgeries, stern regulatory environment for product approval, and growing popularity of minimally invasive surgeries.
The bone graft substitutes segment contributed to one-third share in the overall biosurgery market in 2015. This segment covers products such as cell-based matrices, bone morphogenetic proteins, demineralized bone matrix, and synthetic graft extenders. However, surgical sealant agents segment is expected to grow at the highest growth rate during the forecast period because of the availability of multifunctional products. The neuro- and spine surgery application segment is projected to dominate the market due to high penetration of bone graft substitute products usage in the surgeries. Also, current biologics products are more popular compared to synthetic biosurgical products, and this trend is expected to continue during the analysis period.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/1235
Key findings of Biosurgery Market:
- Surgical sealants are projected to be the fastest growing segment in the biosurgery market with a CAGR of 10.7% from 2015 to 2022.
- Hemostatic agents segment is expected to overtake the bone graft substitute segment, and reach $4.3 billion by 2022.
- Neuro- and spine surgery application segment is projected to dominate this market throughout the forecast period.
- Biologic biosurgical products segment would continue to lead the biosurgery market with about three fourth of the market share in 2015.
- Asia-Pacific is projected to be the fastest growing biosurgery market with a CAGR of 10.7% from 2015 to 2022.
The key companies profiled in this report are Medtronic PLC, Baxter International Inc., C. R. Bard Inc., Johnson and Johnson, Stryker Corporation, Sanofi S.A., Atrium Medical Corporation (Maquet Getinge Group), Hemostasis LLC, CryoLife Inc., and Kuros Bioscience.
Get 20% Free Customization In This Report @ https://www.alliedmarketresearch.com/request-for-customization/1235
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Biosurgery Market Is Increasing Faster to Reach $12.7 Billion and Predicted to Show Highest Growth Rates by 2022
Global Biosurgery Market was valued at $6,912.2 million in 2014 and is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% by 2014 – 2022.